Next-Gen Hormonal Intrauterine Devices (IUDs) : Market Forecast, Transformation, and Long-Term Trajectories
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Hormonal Intrauterine Devices (IUDs) Market Growth Evolved From 2024 To 2025, And What’s Ahead?
The market size for hormonal intrauterine devices (IUDs) has seen a quick expansion in previous years. It’s projected to increase from $2.61 billion in 2024 to $2.87 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. Factors such as the creation of safer and enhanced hormonal solutions, a surge in demand for long-term contraceptive methods, increasing suggestions from healthcare professionals, heightened public knowledge on birth control choices, and progression in medical tech and device structure were contributing elements to the growth observed in the past period.
The market size for hormonal intrauterine devices (iuds) is projected to experience significant growth in the coming years, reaching $4.29 billion in 2029 with a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period can be tied to increasing awareness of contraceptive options, a rising preference for durable, reversible contraception, improvements in the safety and efficiency of the devices, an expanding focus on personalized healthcare, and wider accessibility through healthcare professionals. The forecast period is also expected to witness trends such as advancements in contraceptive device technology, increased tailoring of contraceptive options to individual needs, the growth in patient-centered healthcare methodologies, a heightened demand for sustainable and green products, and the invention of new contraceptive products.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19091&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Hormonal Intrauterine Devices (IUDs) Market?
The anticipated rise in unplanned pregnancies is set to fuel the expansion of the hormonal intrauterine devices market. Unplanned pregnancies are those that weren’t anticipated or desired at the point of conception, and they can happen due to various factors such as contraceptive failure, unavailability of birth control, misuse of contraception, or sexual violence. The lack of adequate access to effective contraception amplifies the risk of unplanned pregnancies as it diminishes people’s control over their reproduction choices. Hormonal IUDs, being extremely effective in preventing conception with a less than 1% failure rate, offer lasting protection (from 3 to 7 years, depending on the model) and stand out as a trustworthy solution for those looking to prevent unplanned pregnancies. For example, data from the Office for Health Improvement & Disparities, a government entity of the Department of Health and Social Care of the UK, recorded that residents of England and Wales underwent 123,219 abortions from January to June 2022, reflecting a 17% increase from the same timeline in 2021. Therefore, the hormonal intrauterine devices market is experiencing growth driven by the rise in unplanned pregnancies.
Which Key Market Segments Comprise the Hormonal Intrauterine Devices (IUDs) Market and Drive Its Revenue Growth?
The hormonal intrauterine devices (iuds)market covered in this report is segmented –
1) By Type: 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
2) By Device Design: Framed Intrauterine Devices, Frameless Intrauterine Devices
3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
4) By Application: Age 20-24, Age 25-34, Age 35-44, Other Applications
Subsegments:
1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=19091&type=smp
Which Areas Are Leading Regions in the Hormonal Intrauterine Devices (IUDs) Market Expansion Across the Globe?
North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (IUDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theHormonal Intrauterine Devices (IUDs) Market Over the Coming Years?
Prominent companies in the hormonal intrauterine devices market are concentrating on the creation of improved products such as levonorgestrel-releasing intrauterine systems, aiming to offer more customized contraceptive options for women. The levonorgestrel-releasing intrauterine systems (LNG-IUS) are hormonal intrauterine devices that consistently discharge a dose of levonorgestrel, a man-made progestin, into the uterus. This hormone makes the cervical mucus thick and modifies the uterine lining to stop sperm from making contact with the egg. For example, Medicines360, a pharmaceutical entity based in the United States and committed to enhancing women’s reach to vital medicines and health goods, launched the FDA-approved LILETTA in November 2022. With approval for up to 8 years of contraception and up to 5 years for heavy menstrual bleeding treatment, LILETTA is one of the most enduring hormonal IUDs in the U.S. It is nearly 99% successful in warding off pregnancy across diverse groups. The device, equipped with an ergonomic inserter for easy positioning during a consultation, can be removed by a healthcare professional at any time. LILETTA is available on prescription and is offered at a discounted rate via the 340B drug pricing program, furthering Medicines360’s objective to boost women’s healthcare accessibility.
View the full report here:
How Is the Hormonal Intrauterine Devices (IUDs) Market Conceptually Defined?
Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices inserted into the uterus that release progestin, a synthetic hormone. They prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to hinder implantation, and sometimes suppressing ovulation. They can also reduce menstrual bleeding and cramping and may even stop periods altogether.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19091
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
